Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.228,87
0,12%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Intra Cellular Therapies Inc (ITCI) Intra Cellular Therapies Inc (ITCI) Notizie

ITCI

Intra Cellular Therapies (ITCI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ITCI
DataOraFonteTitoloSimboloCompagnia
11/12/202414:00GlobeNewswire Inc.Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual MeetingNASDAQ:ITCIIntra Cellular Therapies Inc
07/12/202400:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
05/12/202422:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
03/12/202413:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
03/12/202413:30GlobeNewswire Inc.Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive TherapyNASDAQ:ITCIIntra Cellular Therapies Inc
19/11/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Participate in Three Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
08/11/202423:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ITCIIntra Cellular Therapies Inc
07/11/202414:00GlobeNewswire Inc.Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI CongressNASDAQ:ITCIIntra Cellular Therapies Inc
05/11/202413:00GlobeNewswire Inc.Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with SchizophreniaNASDAQ:ITCIIntra Cellular Therapies Inc
30/10/202412:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITCIIntra Cellular Therapies Inc
30/10/202412:30GlobeNewswire Inc.Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales GuidanceNASDAQ:ITCIIntra Cellular Therapies Inc
17/10/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and WebcastNASDAQ:ITCIIntra Cellular Therapies Inc
23/09/202414:00GlobeNewswire Inc.Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology CongressNASDAQ:ITCIIntra Cellular Therapies Inc
28/08/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Present at Three Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
15/08/202400:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
08/08/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
07/08/202413:40GlobeNewswire Inc.Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial OfficerNASDAQ:ITCIIntra Cellular Therapies Inc
07/08/202413:30GlobeNewswire Inc.Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales GuidanceNASDAQ:ITCIIntra Cellular Therapies Inc
24/07/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and WebcastNASDAQ:ITCIIntra Cellular Therapies Inc
18/06/202413:30GlobeNewswire Inc.Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive DisorderNASDAQ:ITCIIntra Cellular Therapies Inc
10/06/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
29/05/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
23/05/202414:00GlobeNewswire Inc.Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual MeetingNASDAQ:ITCIIntra Cellular Therapies Inc
08/05/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Participate in Two Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
07/05/202413:30GlobeNewswire Inc.Intra-Cellular Therapies Reports First Quarter 2024 Financial ResultsNASDAQ:ITCIIntra Cellular Therapies Inc
30/04/202414:00GlobeNewswire Inc.Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and WebcastNASDAQ:ITCIIntra Cellular Therapies Inc
24/04/202422:01GlobeNewswire Inc.Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:ITCIIntra Cellular Therapies Inc
18/04/202402:46GlobeNewswire Inc.Intra-Cellular Therapies Prices Public Offering of Common StockNASDAQ:ITCIIntra Cellular Therapies Inc
16/04/202422:06GlobeNewswire Inc.Intra-Cellular Therapies Announces Proposed Public Offering of Common StockNASDAQ:ITCIIntra Cellular Therapies Inc
16/04/202413:00GlobeNewswire Inc.Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive DisorderNASDAQ:ITCIIntra Cellular Therapies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ITCI

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
CPR
Davide Campari
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
TIT
Telecom Italia
BIT
IVG
Iveco Group NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network